Cart
sales@molnova.com
Home - Products - Membrane Transporter/Ion Channel - BCRP - Triclabendazole sulfoxide

Triclabendazole sulfoxide

CAS No. 100648-13-3

Triclabendazole sulfoxide( TCBZ-SO )

Catalog No. M28180 CAS No. 100648-13-3

Triclabendazole sulfoxide is a main plasma metabolite of Triclabendazole. Triclabendazole sulfoxide inhibits membrane transporter ABCG2/BCRP and exhibits anti-parasite effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 138 Get Quote
10MG 206 Get Quote
25MG 371 Get Quote
50MG 552 Get Quote
100MG 785 Get Quote
500MG 1602 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Triclabendazole sulfoxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Triclabendazole sulfoxide is a main plasma metabolite of Triclabendazole. Triclabendazole sulfoxide inhibits membrane transporter ABCG2/BCRP and exhibits anti-parasite effects.
  • Description
    Triclabendazole sulfoxide is a main plasma metabolite of Triclabendazole. Triclabendazole sulfoxide inhibits membrane transporter ABCG2/BCRP and exhibits anti-parasite effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TCBZ-SO
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    BCRP
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100648-13-3
  • Formula Weight
    375.65
  • Molecular Formula
    C14H9Cl3N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CS(=O)c1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Levin, Andrew D, et, al. Methods of treating cancer using trimetazidine-based compounds.WO2020190671A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • YHO-13351 free base

    YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

  • Ko-143

    A nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM.

  • YHO-13177

    YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

Sign In Join Free